Hybrid Magneto-Plasmonic Nanostructures for Enhanced Dual-Mode Hyperthermia.

Authors

Amirhossein Sanchooli, Patricia de la Presa

Published in

Nanomaterials (Basel, Switzerland). Volume 16. Issue 15. Jul 29, 2026. Epub Jul 29, 2026.

Abstract

This study addresses a major challenge in hyperthermia therapy: achieving fast and efficient heat generation in target tissues. A novel magneto-plasmonic nanostructure is developed by combining gold nanorods (GNRs) and iron oxide nanoparticles (IONPs), each synthesized independently to compare their individual and combined heating performance. A key innovation was the use of (3-mercaptopropyl)trimethoxysilane (MPTMS) as a covalent linker, enabling the stable integration of both components into a single hybrid system. Under simultaneous near-infrared (NIR) laser and alternating magnetic field exposure, the hybrid nanostructure exhibited a rapid and intense temperature rise, surpassing the effects of either material alone. A control sample consisting of a physical mixture of the two components (GNR + IONP) reached SAR values comparable to those of the covalently linked hybrid (GNR + MPTMS + IONP) under simultaneous excitation, the two being equal within experimental error. Although the chemical linkage modifies the optical absorbance of the GNRs and may partially restrict the Brownian relaxation of the magnetic nanoparticles, these effects do not translate into a measurable loss of heating efficiency under combined activation. Importantly, the covalent linkage yields a robust, structurally stable assembly whose components move together-an essential requirement for functionalities such as magnetic guidance and targeted delivery of the whole nanostructure, which a simple physical mixture cannot provide. As a physicochemical proof of concept, these results establish the dual-mode heating performance of the hybrid nanostructure in aqueous suspension and motivate the biological evaluation required for any future therapeutic use.

PMID:
42584331
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.